Anesthesia Devices Market Size, Share, and Trends 2024 to 2033

Anesthesia Devices Market (By Product: Anesthesia Delivery Machine, Anesthesia Disposables & Accessories, Anesthesia Monitors, Anesthesia Information Management Systems (AIMS); By Type: General Anesthesia, Local Anesthesia; By Application; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : February 2024
  • Report Code : 1900
  • Category : Healthcare

Anesthesia Devices Market Size to Reach USD 34.29 Bn by 2033

The global anesthesia devices market size was valued at USD 15.97 billion in 2023 and is expected to hit around USD 34.29 billion by 2033 and is poised to grow at a compound annual growth rate (CAGR) of 8.01% from 2024 to 2033.

Anesthesia Devices Market Size 2024 to 2033

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways:

  • By product, the anesthesia delivery machines segment has contributed the highest market share of over 49.67% in 2023.
  • By application, the cardiology segment accounted highest market share of 25.01% in 2023.
  • By end user, the hospital segment represented the highest market share of over 58.59% in 2023.
  • By region, the North America region accounted for 41.86% of the market share in 2023.

Anesthesia Devices Market in the U.S. 2024 to 2033

The U.S. anesthesia devices market size was estimated at USD 6.09 billion in 2023 and is anticipated to reach around USD 12.37 billion by 2033, poised to grow at a CAGR of 7.43% from 2024 to 2033.

U.S. Anesthesia Devices Market Size 2024 to 2033

The North American market has dominated this segment as a result of the rapid adoption of advanced technologies and equipments for surgeries and procedures. The increasing prevalence of chronic diseases which is clubbed with upgraded technology helps the market to record a considerable growth during the forecast period. The increasing acceptance for the use of modern technologies for surgical procedures has boosted the economy enormously. The Asia-Pacific region has also helped to boost the market significantly owing to the increasing demand for modern technology for treatment and surgical procedures. The rapid growth in the geriatric population pertaining to the increased life expectancy of the people has given rise to a number of chronic diseases and other systemic disorders which in-turn demand the use of advanced equipments for treatment. The European nations along with the middle eastern region has contributed significantly to the growth of the market.

Anesthesia Devices Market Share, By Region, 2023 (%)

 

Market Overview:

These devices are mainly used during surgical procedures where pain is inevitable. In order to control the pain during the surgical procedures these devices are put into use. It is also used in order to have a control over the breathing of the patient during the surgical procedure the blood pressure of the patient is also managed with the help of these devices which is likely to shoot or fall When the surgical procedure is being carried out as there is an alteration in the flow of blood of the patient. The heart rhythm and rate are very essential and it is required to be controlled as it directly has an effect over the blood pressure of the individual undergoing the surgical procedure. It is also sometimes used in order to have a control over the anxiety of the patient which is caused due to the anticipations made by the patient regarding the surgical procedures. It is a condition caused by the device where the patient loses his consciousness and sensation and is practically seen to be in a state of paralysis where they cannot feel or sense anything so that the surgical procedure can be carried out easily without causing discomfort to the patient.

These procedures do have they are only set of negative impacts on the health of the individual which is seen to be present after the effect of the medicine is completed. Since the breathing frequency of the undo visual is altered there are partial chances of hypoxia which is paused during the surgical procedures and hence the patient is in a confused state of mind after the effect of anesthesia is completed. Once the effect of the medicine is over the patient experiences tremendous pain and discomfort as a result of the procedure which was carried out on the body of the patient. Long term side effects are noticed at the site of administration Which are difficult to deal with for the patient. Pain and swelling at the site of administration becomes the most common complaint experienced by the patient. Due to the increasing surgical procedures globally the use of anesthesia devices has increased drastically in the market. The rapid increase in chronic diseases have also increase the number of surgeries which are carried out worldwide. The surgical procedures which are majorly carried out globally include the cardiovascular system, neurological system and orthopedics as they are usually seem to be affected. The increasing rate of high velocity accidents I've given rise to the number of fractures which in turn gives a boost to the orthopedic surgeries carried out. 

The occurrence of the pandemic had a major impact on the anesthesia devices market which was proved to be a negative one due to the strict lockdowns and restricted movement which was imposed by the government. The government guidelines along with the hospitals made strict regulations regarding the surgical procedures to be performed in the hospitals. The hospitals opted for elective surgical procedures only in order to avoid the risk of cross infection to the medical staff and doctors. The other optional surgeries were kept on hold which hampered the growth of the market due to lack of operative procedures being performed. The various types of reactions which are seen to be produced in the human body to chemically formulated medicines are proving to be a restraining factor for the growth of the market. The physical ailments which are followed after the administration of the anesthesia have hampered the growth of the market.

Anesthesia Devices Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 8.01%
Market Size in 2023 USD 15.97 Billion
Market Size by 2033 USD 34.29 Billion
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Product, Type, Application, End User, Geography
Companies Mentioned

Ambu A/S, Becton and Dickinson, General Electric, 3M Company, Draegerwerk AG & Co. KGAA., Smith Medical, Koninklijke Philips N.V., B. Braun Melsungen AG, SunMed, Teleflex Incorporated


Growth Factors

The various key players are providing lucrative offers to the consumers as the patients for the chronic diseases are increasing every day. The number of patients belonging to the neurological department and the cardiovascular department have increased beyond limits. As a result of the sedentary lifestyle which is practice in most of the developed countries like the US and Brazil have given rise to numerous chronic diseases limitlessly which has helped to boost the market for the anesthesia devices. Though a barrier was created by the pandemic in the functioning of the hospitals for surgeries and regular patient follow-up.

The market was able to balance itself as the surgeries took place on later dates depending upon their emergency levels. Still a negative impact was being sensed as there was a loss of a certain category of patients. With the advancement in the technology processes which have been adopted by the developed nations, hospitals have become extremely specific regarding the comfort of the patients and hence use the most modern methods to deal with them in order to give excellent facilities. Hence the number of human errors and side effects which were produced previously due to the process of injecting anesthesia have been reduce greatly.

Positive response has been obtained from the patients with the introduction of these new devices with advanced mechanism. The anesthesia device is market had faced multiple challenges in terms of the demand and supply chain during the post lockdown phase. After the reversal of the lockdown phase and restoration of the regular movement of the population the hospitals faced a surge in the number of patients which were previously postponed or lined-up for their surgeries due to the occurrence of the pandemic. This creates a shortage of the resources to be supplied to the patients and hence the procedures were disrupted from their schedule. With the use of modern technology used for the anesthesia procedures the swelling and pain at the site of injection were managed quiet well with lesser side effects were incurred upon the patient. This helped the market to create a confidence among the consumers to opt for such surgical procedures, hence the growth was seen to be strengthened during the forecast period. On the other hand, the high cost associated with these advanced equipment's and techniques imposes an additional barrier in the growth phase of the market.

The developing and under developed nations do not have such a strong economic foothold to purchase or develop such advanced technologies which hampers the growth of the market. Whereas, the developed nations have shown a considerable growth as a result of the high disposable income available with the population and hence a higher acceptance to the use of modern technology for surgical procedures is observed in the market. The success rate of the procedures too is seen to rise with the use of modern technologies in the anesthesia devices market. The condition of the patient is displayed in a better format which helps the human mind to take better decisions and thus avoid unexpected errors. It has proved to be a boon to the mankind by reducing the risks involved in this procedure. These various factors will help the market to record a high revenue return during the forecast period.

Market Dynamics

Driver

High demand for cardiovascular procedures

Cardiovascular diseases (CVDs) such as coronary artery disease, hypertension, and heart failure are leading causes of morbidity and mortality worldwide. With the rising incidence of CVDs, there is a growing demand for cardiovascular procedures such as angioplasty, cardiac catheterization, bypass surgery, and implantation of cardiac devices. Anesthesia is essential for ensuring patient comfort, safety, and optimal outcomes during these invasive cardiovascular procedures. The anesthesia devices market has witnessed significant technological advancements, leading to the development of sophisticated anesthesia delivery systems, monitoring devices, and airway management tools. These advancements enable anesthesiologists to deliver precise and customized anesthesia care, monitor vital signs in real-time, and respond promptly to intraoperative changes, enhancing patient safety and procedural outcomes, particularly in complex cardiovascular interventions.

Restraint

The risk associated with regulatory hurdles

Anesthesia devices are subject to stringent regulatory standards and certification requirements to ensure patient safety and efficacy. Compliance with these regulations adds complexity and costs to the development, manufacturing, and marketing of anesthesia devices, potentially slowing down market growth. While anesthesia is essential for surgical procedures, it also carries inherent risks, including adverse reactions, complications, and patient morbidity or mortality. Concerns about anesthesia-related risks may lead to reluctance among patients and healthcare providers to undergo or administer anesthesia, affecting the demand for anesthesia devices.

Opportunity

Integration of customized anesthesia

Customized anesthesia solutions allow for tailored dosing and delivery of anesthetic agents based on individual patient characteristics, such as age, weight, medical history, and physiological parameters. This personalized approach helps minimize the risk of adverse events, such as over-sedation or inadequate anesthesia, thereby enhancing patient safety and comfort during surgical procedures. Integrated anesthesia devices streamline anesthesia delivery and monitoring processes, reducing the need for manual adjustments and allowing for more efficient anesthesia management. By automating routine tasks and providing intuitive interfaces for anesthesia control and monitoring, customized anesthesia systems help healthcare providers save time, reduce errors, and optimize workflow efficiency in the operating room.

Product Insights

On the basis of product, the anesthesia delivery machine dominates the segment globally and is forecasted to continue its performance in the coming years too pertaining to the rapid technological advancements that are experienced in this field. Anesthesia disposables and accessories presents itself as the next competitor which has shown a considerable amount of growth in the market as without it the procedures remain incomplete. Laryngoscopes and anesthesia circuits too have shown a good performance depending upon the market. HME, anesthesia masks and many other products are in line after these which have supported the market growth during the forecast period. Anesthesia monitors are one of the important players in this category as they help to monitor the condition of the patient which is very important.

Global Anesthesia Devices Market, By Product, 2021-2023 (USD Million)

Product 2021 2022 2023
Anesthesia Delivery Machine 6,931.7 7,411.0 7,933.1
Anesthesia Disposables & Accessories 2,370.4 2,536.0 2,716.4
Anesthesia Monitors 4,149.3 4,456.7 4,792.7
Anesthesia Information Management Systems (AIMS) 467.7 497.2 529.1

 

Application Insights

The cardiology segment dominated the anesthesia devices market with the largest share of 25.01% in 2023. Chronic cardiovascular conditions, such as heart failure, arrhythmias, and valvular heart disease, often require interventional procedures or device implantation, which may involve anesthesia administration. As the prevalence of these conditions continues to rise globally, the demand for anesthesia devices in the cardiology segment is expected to grow accordingly. Cardiac surgeries, including coronary artery bypass grafting (CABG), valve replacement, and cardiac transplantation, are complex procedures that require meticulous anesthesia management. Anesthesia devices designed for cardiac anesthesia offer advanced features, such as cardiopulmonary bypass integration, transesophageal echocardiography (TEE) monitoring, and temperature management, to support the unique requirements of these surgeries.

Anesthesia Devices Market Share, By Application, 2023 (%)

End User Insights

Hospitals being the most common place to be visited in the event of a surgical procedure becomes the leading segment and is projected to rule the market in the near future too. The varied setup that is provided by them well equipped with various other accessory facilities for the patients has helped them to dominate this segment. Clinics and ambulatory service units fall next in-line which mainly get included in the dental and opthalmology sector where primary procedures are taken care of by the doctors.

Recent Developments

  • In January 2020, a new Altan group of anesthesia stations were launched by Drager at Arab Health. This was formulated to simplify the procedures in order to make working conditions feasible for the medical fraternity. 

Key market players

  • Ambu A/S
  • Becton and Dickinson
  • General Electric
  • 3M Company
  • Draegerwerk AG & Co. KGAA.
  • Smith Medical
  • Koninklijke Philips N.V.
  • B. Braun Melsungen AG
  • SunMed
  • Teleflex Incorporated

 Segments Covered

By Product

  • Anesthesia Delivery Machine
  • Anesthesia Disposables & Accessories
    • Laryngoscopes
    • HME
    • Anesthesia Circuits
    • Anesthesia Masks
    • Others
  • Anesthesia Monitors
  • Anesthesia Information Management Systems (AIMS)

By Type

  • General Anesthesia
  • Local Anesthesia

By Application

  • Cardiology
  • Neurology
  • Urology
  • Orthopedics
  • Dental
  • Ophthalmology
  • Others

By End User

  • Clinics
  • Ambulatory Service Centers
  • Hospitals

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

The global anesthesia devices market size was accounted at USD 15.97 billion in 2023 and it is expected to reach around USD 34.29 billion by 2033.

The global anesthesia devices market is poised to grow at a CAGR of 8.01% from 2024 to 2033.

The major players operating in the anesthesia devices market are Ambu A/S, Becton and Dickinson, General Electric, 3M Company, Draegerwerk AG & Co. KGAA., Smith Medical, Koninklijke Philips N.V., B. Braun Melsungen AG, SunMed, Teleflex Incorporated

The rapid modernization and urbanization of the world has given rise to a large number of chronic diseases which requires only surgical procedures for their treatment. This proves to be a driving factor for the market.

North America region will lead the global anesthesia devices market during the forecast period 2024 to 2033.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Anesthesia Devices Market 

5.1. COVID-19 Landscape: Anesthesia Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Anesthesia Devices Market, By Product

8.1. Anesthesia Devices Market, by Product, 2024-2033

8.1.1. Anesthesia Delivery Machine

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Anesthesia Disposables & Accessories

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Anesthesia Monitors

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Anesthesia Information Management Systems (AIMS)

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Anesthesia Devices Market, By Type

9.1. Anesthesia Devices Market, by Type e, 2024-2033

9.1.1. General Anesthesia

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Local Anesthesia

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Anesthesia Devices Market, By Application 

10.1. Anesthesia Devices Market, by Application, 2024-2033

10.1.1. Cardiology

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Neurology

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Urology

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Orthopedics

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Dental

10.1.5.1. Market Revenue and Forecast (2021-2033)

10.1.6. Ophthalmology

10.1.6.1. Market Revenue and Forecast (2021-2033)

10.1.7. Others

10.1.7.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Anesthesia Devices Market, By End User 

11.1. Anesthesia Devices Market, by End User, 2024-2033

11.1.1. Clinics

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Ambulatory Service Centers

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Herceptin

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Hospitals

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Anesthesia Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Forecast, by Type (2021-2033)

12.1.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Forecast, by End User (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End User (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Forecast, by End User (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End User (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End User (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End User (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Forecast, by End User (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End User (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End User (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End User (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Forecast, by End User (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End User (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End User (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End User (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End User (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End User (2021-2033)

Chapter 13. Company Profiles

13.1. Ambu A/S

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Becton and Dickinson

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. General Electric

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. 3M Company

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Draegerwerk AG & Co. KGAA.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Smith Medical

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Koninklijke Philips N.V.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. B. Braun Melsungen AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. SunMed

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Teleflex Incorporated

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

 

15.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client